Absci (ABSI) Intangibles (2021 - 2026)
Absci's (ABSI) quarterly Intangibles came in at $40.8 million in Q1 2026, down 7.43% year-on-year from $44.0 million in Q1 2025, and down 1.8% quarter-over-quarter from $41.5 million in Q4 2025.
Absci (ABSI) Intangibles (2021 - 2026) Analysis & Trends
Absci has disclosed Intangibles across 6 years of filings, most recently posting $40.8 million for Q1 2026.
- Intangibles for Q1 2026 came in at $40.8 million, down 7.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.8 million (down 7.43% YoY), and the FY2025 annual result was $41.5 million, down 7.51% from the prior year.
- Intangibles came in at $40.8 million for Q1 2026 at Absci, down from $41.5 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $57.1 million in Q1 2022 to a low of $40.8 million in Q1 2026.
- The 5-year median for Intangibles is $47.4 million (2024), against an average of $47.6 million.
- Across the five-year window, Intangibles fell 5.94% in 2022 and retreated 11.08% in 2023, its largest moves.
- Absci's Intangibles stood at $51.6 million in 2022, then retreated by 6.53% to $48.3 million in 2023, then retreated by 6.98% to $44.9 million in 2024, then slipped by 7.51% to $41.5 million in 2025, then declined by 1.8% to $40.8 million in 2026.
- The last three Intangibles figures came in at $40.8 million (Q1 2026), $41.5 million (Q4 2025), and $42.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 40.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.77 Mn |
| Dec 31, 2025 | 41.51 Mn |
| Sep 30, 2025 | 42.36 Mn |
| Jun 30, 2025 | 43.20 Mn |
| Mar 31, 2025 | 44.04 Mn |
| Dec 31, 2024 | 44.88 Mn |
| Sep 30, 2024 | 45.73 Mn |
| Jun 30, 2024 | 46.57 Mn |
| Mar 31, 2024 | 47.41 Mn |
| Dec 31, 2023 | 48.25 Mn |
| Sep 30, 2023 | 49.10 Mn |
| Jun 30, 2023 | 49.94 Mn |
| Mar 31, 2023 | 50.78 Mn |
| Dec 31, 2022 | 51.62 Mn |
| Sep 30, 2022 | 52.47 Mn |
| Jun 30, 2022 | 53.31 Mn |
| Mar 31, 2022 | 57.11 Mn |
| Dec 31, 2021 | 54.99 Mn |
| Sep 30, 2021 | 55.84 Mn |
| Jun 30, 2021 | 56.68 Mn |